Related references
Note: Only part of the references are listed.CX3CL1 promotes lung cancer cell migration and invasion via the Src/focal adhesion kinase signaling pathway
Wangmi Liu et al.
ONCOLOGY REPORTS (2019)
Fractalkine induces angiogenic potential in CX3CR1-expressing monocytes
Youngrok Park et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2018)
Safety, pharmacokinetics, and efficacy of E6011, an antifractalkine monoclonal antibody, in a first-in-patient phase 1/2 study on rheumatoid arthritis
Yoshiya Tanaka et al.
MODERN RHEUMATOLOGY (2018)
CX3CL1/fractalkine enhances prostate cancer spinal metastasis by activating the Src/FAK pathway
Peng Liu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Angiogenic factor-driven inflammation promotes extravasation of human proangiogenic monocytes to tumours
Adama Sidibe et al.
NATURE COMMUNICATIONS (2018)
Monocyte chemoattractant protein 1 and fractalkine play opposite roles in angiogenesis via recruitment of different macrophage subtypes
Lei Chen et al.
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY (2018)
Immunological Approaches Towards Cancer and Inflammation: A Cross Talk
Xinglong Qu et al.
FRONTIERS IN IMMUNOLOGY (2018)
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts
Marina Bolzoni et al.
HAEMATOLOGICA (2017)
Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma
Caterina Musolino et al.
MEDIATORS OF INFLAMMATION (2017)
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts
Marina Bolzoni et al.
HAEMATOLOGICA (2017)
Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20
B. Dalla Palma et al.
LEUKEMIA (2016)
Role of CX3CL1 in Diseases
WangMi Liu et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2016)
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target
Marina Bolzoni et al.
BLOOD (2016)
Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma
Jesus Delgado-Calle et al.
CANCER RESEARCH (2016)
Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo
P. Storti et al.
LEUKEMIA (2016)
Novel Small-Molecule CX3CR1 Antagonist Impairs Metastatic Seeding and Colonization of Breast Cancer Cells
Fei Shen et al.
MOLECULAR CANCER RESEARCH (2016)
Therapeutic intervention of inflammatory/immune diseases by inhibition of the fractalkine (CX3CL1)-CX3CR1 pathway
Toshio Imai et al.
INFLAMMATION AND REGENERATION (2016)
Role of chemokine CX3CL1 in progression of multiple myeloma via CX3CR1 in bone microenvironments
Akinori Wada et al.
ONCOLOGY REPORTS (2015)
The proportion of CD16+CD14dim monocytes increases with tumor cell load in bone marrow of patients with multiple myeloma
Anne M. Sponaas et al.
IMMUNITY INFLAMMATION AND DISEASE (2015)
Endothelin-1 Activation of the Endothelin B Receptor Modulates Pulmonary Endothelial CX3CL1 and Contributes to Pulmonary Angiogenesis in Experimental Hepatopulmonary Syndrome
Junlan Zhang et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Cytoskeletal confinement of CX3CL1 limits its susceptibility to proteolytic cleavage by ADAM10
Harikesh S. Wong et al.
MOLECULAR BIOLOGY OF THE CELL (2014)
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
S. Vincent Rajkumar et al.
LANCET ONCOLOGY (2014)
Role of Fractalkine/CX3CL1 and Its Receptor in the Pathogenesis of Inflammatory and Malignant Diseases with Emphasis on B Cell Malignancies
Elisa Ferretti et al.
MEDIATORS OF INFLAMMATION (2014)
Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis
Anna Ridderstad Wollberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Recruitment of monocytes/macrophages in different tumor microenvironments
Heon-Woo Lee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2013)
Novel cooperation between CX3CL1 and CCL26 inducing NK cell chemotaxis via CX3CR1: a possible mechanism for NK cell infiltration of the allergic nasal tissue
A. E. El-Shazly et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2013)
Chemokine receptor CX3CR1 contributes to macrophage survival in tumor metastasis
Jiao Zheng et al.
MOLECULAR CANCER (2013)
Fractalkine (CX3CL1) and Its Receptor CX3CR1 May Contribute to Increased Angiogenesis in Diabetic Placenta
Dariusz Szukiewicz et al.
MEDIATORS OF INFLAMMATION (2013)
Role of CX3CR1 Receptor in Monocyte/Macrophage Driven Neovascularization
Arun H. S. Kumar et al.
PLOS ONE (2013)
Anti-Inflammatory Effect of the Proteasome Inhibitor Bortezomib on Endotoxin-Induced Uveitis in Rats
Fang-Ting Chen et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
CD16 (FcR gamma III) as a potential marker of osteoclast precursors in psoriatic arthritis
Yahui Grace Chiu et al.
ARTHRITIS RESEARCH & THERAPY (2010)
A SNP Microarray and FISH-Based Procedure to Detect Allelic Imbalances in Multiple Myeloma: An Integrated Genomics Approach Reveals a Wide Gene Dosage Effect
Luca Agnelli et al.
GENES CHROMOSOMES & CANCER (2009)
Role of CX3CL1/Fractalkine in Osteoclast Differentiation and Bone Resorption
Keiichi Koizumi et al.
JOURNAL OF IMMUNOLOGY (2009)
Protective roles of the fractalkine/CX3CL1-CX3CR1 interactions in alkali-induced corneal Neovascularization through enhanced antiangiogenic factor expression
Peirong Lu et al.
JOURNAL OF IMMUNOLOGY (2008)
Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis
Jian-Jang You et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Myeloma cells and bone marrow osteoblast interactions: Role in the development of osteolytic lesions in multiple myeloma
Nicola Giuliani et al.
LEUKEMIA & LYMPHOMA (2007)
Fractalkine stimulates angiogenesis by activating the Raf-1/MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways
Seon-Jin Lee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Chemokines in multiple myeloma
Rohit Aggarwal et al.
EXPERIMENTAL HEMATOLOGY (2006)
Tumor necrosis factor-α induces fractalkine expression preferentially in arterial endothelial cells and mithramycin A suppresses TNF-α-induced fractalkine expression
SY Ahn et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Myeloma cells (5TMM) and their interactions with the marrow marrow environment
E Menu et al.
BLOOD CELLS MOLECULES AND DISEASES (2004)
Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression
S Kumar et al.
BLOOD (2004)
Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy
S Kumar et al.
BONE MARROW TRANSPLANTATION (2004)
Fractalkine in vascular biology - From basic research to clinical disease
H Umehara et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Tumor necrosis factor-α-converting enzyme (ADAM17) mediates GPIbα shedding from platelets in vitro and in vivo
W Bergmeier et al.
CIRCULATION RESEARCH (2004)
Chemoattraction, adhesion and activation of natural killer cells are involved in the antitumor immune response induced by fractalkine/CX3CL1
J Guo et al.
IMMUNOLOGY LETTERS (2003)
Bone marrow angiogenesis and circulating plasma cells in multiple myeloma
S Kumar et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Fractalkine preferentially mediates arrest and migration of CD16+ monocytes
P Ancuta et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Tumor necrosis factor-α-converting enzyme mediates the inducible cleavage of fractalkine
CL Tsou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Fractalkine, a CX3C-chemokine, functions predominantly as an adhesion molecule in monocytic cell line THP-1
H Umehara et al.
IMMUNOLOGY AND CELL BIOLOGY (2001)
Ultrastructure and function of the fractalkine mucin domain in CX3C chemokine domain presentation
AM Fong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
